Anti-Sjogren Syndrome/Scleroderma Autoantigen 1 (SSCA1) Antibodies and Cancer in Systemic Sclerosis

Thanks! Share it with your friends!

You disliked this video. Thanks for the feedback!

Added 1 month ago by miamigo

11 Views

Rheumatology fellow Rachel Wallwork discusses her latest research results on how an antibody in systemic sclerosis patients with cancer may be a key biomarker to predict possible cancer development.

Category: TINA TURNER
Tags: Johns Hopkins Hospital, Johns Hopkins Medicine, Promise of Medicine

Commenting disabled.

Sign in

Anti-Sjogren Syndrome/Scleroderma Autoantigen 1 (SSCA1) Antibodies and Cancer in Systemic Sclerosis

Up Next